Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research

Current Pharmaceutical Biotechnology

Volumn 11, Issue 2, 2010, Pages 167-174

  Dietz, Gunnar P H ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Antennapedia (penetratin); Arginine rich peptide; HIV Tat; Ischemia; Pep 1; Protein delivery; Stroke; Trojan horse

Indexed keywords

ALPHA SYNUCLEIN; BAG 1 PROTEIN; CELL PENETRATING PEPTIDE; CHAPERONE; CHOLINE ACETYLTRANSFERASE; COPPER ZINC SUPEROXIDE DISMUTASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 20; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK TRANSCRIPTION FACTOR 1; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PENETRATIN; SOMATOMEDIN C; TRANSACTIVATOR PROTEIN; VASOPRESSIN RECEPTOR;

AMINO ACID SEQUENCE; BRAIN ISCHEMIA; CELL STRESS; CELL SURVIVAL; DOPAMINERGIC NERVE CELL; DRUG DELIVERY SYSTEM; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; PARKINSON DISEASE; PROTEIN FUNCTION; REVIEW; SMOOTH MUSCLE RELAXATION;

AMINO ACID SEQUENCE; ANIMALS; BIOMEDICAL RESEARCH; DISEASE; DRUG DELIVERY SYSTEMS; HUMANS; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS;

EQUIDAE;

EID: 77949885837     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110790909731     Document Type: Review

References (104)

1. Ryser, H.J.P. Uptake of protein by mammalian cells: an underdeveloped area. Science, 1968, 159(813), 390-396.
2. Perez, F.; Joliot, A.; Bloch-Gallego, E.; Zahraoui, A.; Triller, A.; Prochiantz, A. Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide. J. Cell Sci., 1992, 102(Pt 4), 717-722.
3. Fawell, S.; Seery, J.; Daikh, Y.; Moore, C.; Chen, L.L.; Pepinsky, B.; Barsoum, J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA, 1994, 91(2), 664-668.
4. Elliott, G.; O'Hare, P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell, 1997, 88(2), 223-233.
5. Pooga, M.; Hallbrink, M.; Zorko, M.; Langel, U. Cell penetration by transportan. FASEB J., 1998, 12(1), 67-77.
6. Schwarze, S.R.; Ho, A.; Vocero-Akbani, A.; Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 1999, 285(5433), 1569-1572.
7. Josephson, L.; Tung, C.H.; Moore, A.; Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem., 1999, 10(2), 186-191.
8. Rothbard, J.B.; Garlington, S.; Lin, Q.; Kirschberg, T.; Kreider, E.; McGrane, P.L.; Wender, P.A.; Khavari, P.A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med., 2000, 6(11), 1253-1257.
9. Morris, M.C.; Depollier, J.; Mery, J.; Heitz, F.; Divita, G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol., 2001, 19(12), 1173-6.
10. Dietz, G.P.H.; Kilic, E.; Bähr, M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol. Cell Neurosci., 2002, 21(1), 29-37.
11. Asoh, S.; Ohsawa, I.; Mori, T.; Katsura, K.; Hiraide, T.; Katayama, Y.;Kimura, M.; Ozaki, D.; Yamagata, K.; Ohta, S. Protection against ischemic brain injury by protein therapeutics. Proc. Natl. Acad. Sci.USA, 2002, 99(26), 17107-17112.
12. Kilic, E.; Dietz, G.P.H.; Hermann, D.M.; Bähr, M. Intravenous TAT-Bcl-xL is protective after middle cerebral artery occlusion in mice. Ann Neurol., 2002, 52(5), 617-622.
13. Kumar, P.; Wu, H.; McBride, J.L.; Jung, K.E.; Kim, M.H.; Davidson, B.L.; Lee, S.K.; Shankar, P.; Manjunath, N. Transvascular delivery of small interfering RNA to the central nervous system. Nature, 2007, 448(7149), 39-43.
14. Dietz, G.P.H.; Bähr, M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell Neurosci., 2004, 27(2), 85-131.
15. Arnoys, E.J.; Wang, J.L. Dual localization: proteins in extracellular and intracellular compartments. Acta Histochem., 2007, 109(2), 89-110.
16. Horvath, I.; Multhoff, G.; Sonnleitner, A.; Vigh, L. Membrane-associated stress proteins: more than simply chaperones 2. Biochim. Biophys. Acta, 2008, 1778(7-8), 1653-1664.
17. Calderwood, S.K.; Mambula, S.S.; Gray, P.J., Jr.; Theriault, J.R. Extracellular heat shock proteins in cell signaling. FEBS. Lett., 2007, 581(19), 3689-3694.
18. Multhoff, G.; Hightower, L.E. Cell surface expression of heat shock proteins and the immune response. Cell Stress Chaperones, 1996, 1(3), 167-176.
19. Beachy, S.H.; Kisailus, A.J.; Repasky, E.A.; Subjeck, J.R.; Wang, X.Y.; Kazim, A.L. Engineering secretable forms of chaperones for immune modulation and vaccine development. Methods, 2007, 43(3), 184-193.
20. Kustanova, G.A.; Murashev, A.N.; Karpov, V.L.; Margulis, B.A.; Guzhova, I.V.; Prokhorenko, I.R.; Grachev, S.V.; Evgen'ev, M.B. Exogenous heat shock protein 70 mediates sepsis manifestations and decreases the mortality rate in rats. Cell Stress Chaperones., 2006, 11(3), 276-286.
21. Kustanova, G.A.; Murashev, A.N.; Guzhova, I.V.; Margulis, B.A.; Prokhorenko, I. R.; Grachev, S.V.; Evgen'ev, M.B. Protective effect of exogenous 70-kDa heat shock protein during endotoxic shock (sepsis). Dokl. Biol. Sci., 2006, 411, 504-507.
22. Kustanova, G.A.; Evgen'ev, M.B.; Karpov, V.L.; Margulis, B.A.; Prokhorenko, I.R.; Grachev, S.V.; Murashev, A.N. Effect of 70 kDa exogenous heat shock protein on biochemical parameters of Wistar rats in endotoxic shock. Dokl. Biol. Sci., 2007, 415, 253-256.
23. Tytell, M. Release of heat shock proteins (Hsps) and the effects of extracellular Hsps on neural cells and tissues. Int. J. Hyperthermia, 2005, 21(5), 445-455.
24. Tytell, M.; Robinson, M.B.; Milligan, C.E. Release of heat shock proteins and their effects when in the extracellular space in the nervous system. In: Heat Shock Proteins and the Brain: Implications for Neurodegenerative Diseases and Neuroprotection; ed. Asea, A.A.A., Brown, I.R., Eds.; Springer Science+Business Media B.V. 2009, pp. 257-272.
25. Tytell, M.; Greenberg, S.G.; Lasek, R.J. Heat shock-like protein is transferred from glia to axon. Brain Res., 1986, 363(1), 161-164.
26. Hightower, L.E.; Guidon, P.T., Jr. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J. Cell Physiol., 1989, 138(2), 257-266.
27. Houenou, L.J.; Li, L.; Lei, M.; Kent, C.R.; Tytell, M. Exogenous heat shock cognate protein Hsc 70 prevents axotomy-induced death of spinal sensory neurons. Cell Stress Chaperones, 1996, 1(3), 161-6.
28. Guzhova, I.; Kislyakova, K.; Moskaliova, O.; Fridlanskaya, I.; Tytell, M.; Cheetham, M.; Margulis, B. In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res., 2001, 914(1-2), 66-73.
29. Yu, Q.; Kent, C.R.; Tytell, M. Retinal uptake of intravitreally injected Hsc/Hsp70 and its effect on susceptibility to light damage. Mol. Vis., 2001, 7, 48-56.
30. Tidwell, J.L.; Houenou, L.J.; Tytell, M. Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration. Cell Stress Chaperones, 2004, 9(1), 88-98.
31. Novoselova, T.V.; Margulis, B.A.; Novoselov, S.S.; Sapozhnikov, A.M.; van der, S.J.; Cheetham, M.E.; Guzhova, I.V. Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation. J. Neurochem., 2005, 94(3), 597-606.
32. Robinson, M.B.; Tidwell, J.L.; Gould, T.; Taylor, A.R.; Newbern, J.M.; Graves, J.; Tytell, M.; Milligan, C.E. Extracellular heat shock protein 70: a critical component for motoneuron survival. J. Neurosci., 2005, 25(42), 9735-9745.
33. Robinson, M.B.; Taylor, A.R.; Gifondorwa, D.J.; Tytell, M.; Milligan, C.E. Exogenous Hsc70, but not thermal preconditioning, confers protection to motoneurons subjected to oxidative stress. Dev. Neurobiol., 2008, 68(1), 1-17.
34. Gifondorwa, D.J.; Robinson, M.B.; Hayes, C.D.; Taylor, A.R.; Prevette, D. M.; Oppenheim, R.W.; Caress, J.; Milligan, C.E. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci., 2007, 27(48), 13173-31180.
35. Fujihara, S.M.; Nadler, S.G. Intranuclear targeted delivery of functional NF-kappaB by 70 kDa heat shock protein. EMBO J., 1999, 18(2), 411-419.
36. Niarchos, D.K.; Perez, S.A.; Papamichail, M. Characterization of a novel cell penetrating peptide derived from Bag-1 protein. Peptides, 2006, 27(11), 2661-2669.
37. Takenaka, I.M.; Leung, S.M.; McAndrew, S.J.; Brown, J.P.; High-tower, L.E. Hsc70-binding peptides selected from a phage display peptide library that resemble organellar targeting sequences3. J. Biol. Chem., 1995, 270(34), 19839-19844.
38. Eguchi, A.; Meade, B.R.; Chang, Y.C.; Fredrickson, C.T.; Willert, K.; Puri, N.; Dowdy, S.F. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat. Biotechnol., 2009, 27(6), 567-571.
39. Lai, Y.; Du, L.; Wong, H.R.; Kochanek, P.M.; Jenkins, L.W.; Dunsmore, K.; Graham, S.H.; Clark, R.S.B. Tat-HSP70 protects neurons from peroxynitrite and glutamate-induced cell death. Society for Neuroscience Abstracts, 2002, Program No. 225.1. 2002.
40. Lai, Y.; Du, L.; Dunsmore, K.E.; Jenkins, L.W.; Wong, H.R.; Clark, R.S. Selectively increasing inducible heat shock protein 70 via TAT-protein transduction protects neurons from nitrosative stress and excitotoxicity. J. Neurochem., 2005, 94(2), 360-366.
41. Wheeler, D.S.; Dunsmore, K.E.; Wong, H.R. Intracellular delivery of HSP70 using HIV-1 Tat protein transduction domain. Biochem. Biophys. Res. Commun., 2003, 301(1), 54-59.
42. Hansen, J.E.; Sohn, W.; Kim, C.; Chang, S.S.; Huang, N.C.; Santos, D.G.; Chan, G.; Weisbart, R.H.; Nishimura, R.N. Antibody-mediated Hsp70 protein therapy. Brain Res., 2006, 1088(1), 187-196.
43. Kwon, J.H.; Kim, J.B.; Lee, K.H.; Kang, S.M.; Chung, N.; Jang, Y.; Chung, J.H. Protective effect of heat shock protein 27 using protein transduction domain-mediated delivery on ischemia/reperfusion heart injury. Biochem. Biophys. Res. Commun., 2007, 363(2), 399-404.
44. Tan, C.Y.; Ban, H.; Kim, Y.H.; Lee, S.K. The heat shock protein 27 (Hsp27) operates predominantly by blocking the mitochondrialin-dependent/ extrinsic pathway of cellular apoptosis. Mol. Cells., 2009, 27(5), 533-538.
45. Lee, J.; Tan, C.Y.; Lee, S.K.; Kim, Y.H.; Lee, K.Y. Controlled delivery of heat shock protein using an injectable microsphere/ hydrogel combination system for the treatment of myocardial infarction. J. Control. Release, 2009, 137(3), 196-202.
46. Kim, S.A.; Chang, S.; Yoon, J.H.; Ahn, S.G. TAT-Hsp40 inhibits oxidative stress-mediated cytotoxicity via the inhibition of Hsp70 ubiquitination. FEBS Lett., 2008, 582(5), 734-740.
47. An, J.J.; Lee, Y.P.; Kim, D.W.; Sohn, E.J.; Jeong, H.J.; Kang, H.W.; Shin, M.J.; Kim, M.J.; Ahn, E.H.; Jang, S.H.; Kang, J.H.; Kang, T.C.; Won, M.H.; Kwon, O.S.; Cho, S.W.; Lee, K.S.; Park, J.; Eum, W.S.; Choi, S.Y. Transduced HSP27 protein protects neuronal cell death by enhancing FALS-associated SOD1 mutant activity. BMB. Rep., 2009, 42(3), 136-141.
48. Nagel, F.; Dohm, C.P.; Bahr, M.; Wouters, F.S.; Dietz, G.P.H. Quantitative evaluation of chaperone activity and neuroprotection by different preparations of a cell-penetrating Hsp70. J. Neurosci., Methods, 2008, 171(2), 226-232.
49. Dietz, G.P.H.; Nagel, F.; Tönges, L.; Dohm, C.; Wouters, F.S.; Ganesa, S.; Bähr, M. Heat shock protein delivered by a cell-penetrating peptide enhances chaperone activity in models for neurodegenerative diseases: Society for Neuroscience Annual Meeting, Atlanta, Georgia, 14-18. October 2006; Society for Neuroscience, 2006.
50. Nagel, F.; Falkenburger, B.H.; Tonges, L.; Kowsky, S.; Poppelmeyer, C.; Schulz, J.B.; Bähr, M.; Dietz, G.P.H. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease. J. Neurochem., 2008, 105(3), 853-864.
51. Albani, D.; Peverelli, E.; Rametta, R.; Batelli, S.; Veschini, L.; Negro, A.; Forloni, G. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70. FASEB J., 2004, 18(14), 1713-1715.
52. Batelli, S.; Albani, D.; Rametta, R.; Polito, L.; Prato, F.; Pesaresi, M.; Negro, A.; Forloni, G. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70. PLoS ONE, 2008, 3(4), e1884.
53. Doeppner, T.R.; Nagel, F.; Dietz, G.P.H.; Weise, J.; Tonges, L.; Schwarting, S.; Bahr, M. TAT-Hsp70-mediated neuroprotection and increased survival of neuronal precursor cells after focal cerebral ischemia in mice. J. Cereb. Blood Flow. Metab., 2009, 29(6), 1187-1196.
54. An, J.J.; Lee, Y.P.; Kim, S.Y.; Lee, S.H.; Lee, M.J.; Jeong, M.S.; Kim, D.W.; Jang, S.H.; Yoo, K.Y.; Won, M.H.; Kang, T.C.; Kwon, O.S.; Cho, S.W.; Lee, K.S.; Park, J.; Eum, W.S.; Choi, S.Y. Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult. FEBS J., 2008, 275(6), 1296-1308.
55. Chang, W.; Song, B.W.; Lim, S.; Song, H.; Shim, C.Y.; Cha, M.J.; Ahn, D.H.; Jung, Y.G.; Lee, D.H.; Chung, J.H.; Choi, K.D.; Lee, S.K.; Chung, N.; Lee, S.K.; Jang, Y.; Hwang, K.C. Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem. Cells, 2009, 27(9),2283-2292.
56. Flynn, C.R.; Komalavilas, P.; Tessier, D.; Thresher, J.; Niederkofler, E.E.; Dreiza, C.M.; Nelson, R.W.; Panitch, A.; Joshi, L.; Brophy, C.M. Transduction of biologically active motifs of the small heat shock-related protein HSP20 leads to relaxation of vascular smooth muscle. FASEB J., 2003, 17(10), 1358-1360.
57. Tessier, D.J.; Komalavilas, P.; McLemore, E.; Thresher, J.; Brophy, C.M. Sildenafil-induced vasorelaxation is associated with increases in the phosphorylation of the heat shock-related protein 20 (HSP20). J. Surg. Res., 2004, 118(1), 21-25.
58. Komalavilas, P.; Penn, R.B.; Flynn, C.R.; Thresher, J.; Lopes, L.B.; Furnish, E.J.; Guo, M.; Pallero, M.A.; Murphy-Ullrich, J.E.; Brophy, C.M. The small heat shock-related protein, HSP20, is a cAMP-dependent protein kinase substrate that is involved in airway smooth muscle relaxation. Am. J. Physiol. Lung Cell Mol. Physiol., 2008, 294(1), L69-L78.
59. Dreiza, C.M.; Brophy, C.M.; Komalavilas, P.; Furnish, E.J.; Joshi, L.; Pallero, M.A.; Murphy-Ullrich, J.E.; von Rechenberg, M.; Ho, Y.S.; Richardson, B.; Xu, N.; Zhen, Y.; Peltier, J.M.; Panitch, A. Transducible heat shock protein 20 (HSP20) phosphopeptide alters cytoskeletal dynamics. FASEB J., 2005, 19(2), 261-263.
60. Tessier, D.J.; Komalavilas, P.; Liu, B.; Kent, C.K.; Thresher, J.S.; Dreiza, C.M.; Panitch, A.; Joshi, L.; Furnish, E.; Stone, W.; Fowl, R.; Brophy, C.M. Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia. J. Vasc. Surg., 2004, 40(1), 106-114.
61. McLemore, E.C.; Tessier, D.J.; Flynn, C.R.; Furnish, E.J.; Komalavilas, P.; Thresher, J.S.; Joshi, L.; Stone, W.M.; Fowl, R.J.; Brophy, C.M. Transducible recombinant small heat shock-related protein, HSP20, inhibits vasospasm and platelet aggregation. Surgery, 2004, 136(3), 573-578.
62. Lopes, L.B.; Furnish, E.J.; Komalavilas, P.; Flynn, C.R.; Ashby, P.; Hansen, A.; Ly, D.P.; Yang, G.P.; Longaker, M.T.; Panitch, A.; Brophy, C.M. Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts. J. Invest. Dermatol., 2009, 129(3), 590-598.
63. Lopes, L.B.; Flynn, C.; Komalavilas, P.; Panitch, A.; Brophy, C.M.; Seal, B.L. Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor. Biochem. Biophys. Res. Commun., 2009, 382(3), 535-539.
64. Schwarze, S.R.; Hruska, K.A.; Dowdy, S.F. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol., 2000, 10(7), 290-295.
65. Wadia, J.S.; Dowdy, S.F. Modulation of cellular function by TAT mediated transduction of full length proteins. Curr. Protein Pept. Sci., 2003, 4(2), 97-104. [66] Nagahara, H.; Vocero-Akbani, A.M.; Snyder, E.L.; Ho, A.; Latham, D.G.; Lissy, N.A.; Becker-Hapak, M.; Ezhevsky, S.A.; Dowdy, S.F. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med., 1998, 4(12), 1449-1452. [67] Derossi, D.; Calvet, S.; Trembleau, A.; Brunissen, A.; Chassaing, G.; Prochiantz, A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem., 1996, 271(30), 18188-18193.
66. Futaki, S.; Suzuki, T.; Ohashi, W.; Yagami, T.; Tanaka, S.; Ueda, K.; Sugiura, Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem., 2001, 276(8), 5836-5840.
67. Dietz, G.P.H.; Bähr, M. Peptide-enhanced cellular internalization of proteins in neuroscience. Brain Res. Bull., 2005, 68(1-2), 103-114.
68. Herve, F.; Ghinea, N.; Scherrmann, J.M. CNS delivery via adsorptive transcytosis. AAPS J., 2008, 10(3), 455-472.
69. Endoh, T.; Ohtsuki, T. Cellular siRNA delivery using cellpenetrating peptides modified for endosomal escape. Adv. Drug Deliv. Rev., 2009, 61(9), 704-709.
70. Meade, B.R.; Dowdy, S.F. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv. Drug Deliv. Rev., 2008, 60(4-5), 530-536.
71. Meade, B.R.; Dowdy, S.F. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv. Drug Deliv. Rev., 2007, 59(2-3), 134-140.
72. Ramon, A.L.; Bertrand, J.R.; Malvy, C. Delivery of small interfering RNA. A review and an example of application to a junction oncogene. Tumori, 2008, 94(2), 254-263.
73. Veldhoen, S.; Laufer, S.D.; Restle, T. Recent developments in Peptide-based nucleic Acid delivery. Int. J. Mol. Sci., 2008, 9(7), 1276-1320.
74. Bullok, K.E.; Gammon, S.T.; Violini, S.; Prantner, A.M.; Villalobos, V.M.; Sharma, V.; Piwnica-Worms, D. Permeation peptide conjugates for in vivo molecular imaging applications. Mol. Imaging, 2006, 5(1), 1-15.
75. Kersemans, V.; Kersemans, K.; Cornelissen, B. Cell penetrating peptides for in vivo molecular imaging applications. Curr. Pharm. Des., 2008, 14(24), 2415-2447.
76. Jones, A.T. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J. Cell Mol. Med., 2007, 11(4), 670-684.
77. Duchardt, F.; Fotin-Mleczek, M.; Schwarz, H.; Fischer, R.; Brock, R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic, 2007, 8(7), 848-866.
78. Edenhofer, F. Protein transduction revisited: novel insights into the mechanism underlying intracellular delivery of proteins. Curr. Pharm. Des., 2008, 14(34), 3628-3636.
79. Vives, E.; Richard, J.P.; Rispal, C.; Lebleu, B. TAT Peptide Internalization: Seeking the Mechanism of Entry. Curr. Protein Pept. Sci., 2003, 4(2), 125-132.
80. Herbig, M.E.; Weller, K.M.; Merkle, H.P. Reviewing biophysical and cell biological methodologies in cell-penetrating peptide (CPP) research. Crit. Rev. Ther. Drug Carr. Syst., 2007, 24(3), 203-255.
81. Torchilin, V.P. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers, 2008, 90(5), 604-610.
82. Torchilin, V.P. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv. Drug Deliv. Rev., 2008, 60(4-5), 548-558.
83. Morris, M.C.; Deshayes, S.; Heitz, F.; Divita, G. Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol. Cell, 2008, 100(4), 201-217.
84. Goun, E.A.; Pillow, T.H.; Jones, L.R.; Rothbard, J.B.; Wender, P.A. Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging 1. Chembiochem., 2006, 7(10), 1497-1515.
85. Abes, R.; Arzumanov, A.; Moulton, H.; Abes, S.; Ivanova, G.; Gait, M.J.; Iversen, P.; Lebleu, B. Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. J. Pept. Sci., 2008, 14(4), 455-460.
86. Lebleu, B.; Moulton, H.M.; Abes, R.; Ivanova, G.D.; Abes, S.; Stein, D.A.; Iversen, P.L.; Arzumanov, A.A.; Gait, M.J. Cell penetrating peptide conjugates of steric block oligonucleotides 1. Adv. Drug Deliv. Rev., 2008, 60(4-5), 517-529.
87. Pujals, S.; Giralt, E. Proline-rich, amphipathic cell-penetrating peptides. Adv. Drug Deliv. Rev., 2008, 60(4-5), 473-484.
88. Henriques, S.T.; Castanho, M.A. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity. J. Pept. Sci., 2008, 14(4), 482-487.
89. Hansen, M.; Kilk, K.; Langel, U. Predicting cell-penetrating peptides. Adv. Drug Deliv. Rev., 2008, 60(4-5), 572-579.
90. Joliot, A.; Prochiantz, A. Homeoproteins as natural Penetratin cargoes with signaling properties. Adv. Drug Deliv. Rev., 2008, 60(4-5), 608-613.
91. Asoh, S.; Ohta, S. PTD-mediated delivery of anti-cell death proteins/ peptides and therapeutic enzymes. Adv. Drug Deliv. Rev., 2008, 60(4-5), 499-516.
92. Dietz, G.P.H.; Bähr, M. Synthesis of cell penetrating peptides and their application in neurobiology. in: Neuroprotection; Borsello, T., Ed.; Totowa, N.J.: The Humana Press Inc., 2007, pp. 181-198.
93. An, J.J.; Lee, Y.P.; Kim, S.Y.; Lee, S.H.; Kim, D.W.; Lee, M.J.; Jeong, M.S.; Jang, S.H.; Kang, J.H.; Kwon, H.Y.; Kang, T.C.; Won, M.H.; Cho, S.W.; Kwon, O.S.; Lee, K.S.; Park, J.; Eum, W.S.; Choi, S.Y. Transduction of familial amyotrophic lateral sclerosis-related mutant PEP-1-SOD proteins into neuronal cells. Mol. Cells, 2008, 25(1), 55-63.
94. Sun, F.; Mi, Z.; Condliffe, S.B.; Bertrand, C.A.; Gong, X.; Lu, X.; Zhang, R.; Latoche, J.D.; Pilewski, J.M.; Robbins, P.D.; Frizzell, R.A. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia. FASEB J., 2008, 22(9), 3255-3263.
95. Fu, A.L.; Huang, S.J.; Sun, M.J. Complementary remedy of aged-related learning and memory deficits via exogenous choline acetyltransferase. Biochem. Biophys. Res. Commun., 2005, 336(1), 268-273.
96. Flynn, C.R.; Smoke, C.C.; Furnish, E.; Komalavilas, P.; Thresher, J.; Yi, Z.; Mandarino, L.J.; Brophy, C.M. Phosphorylation and activation of a transducible recombinant form of human HSP20 in Escherichia coli. Protein. Expr. Purif., 2007, 52(1), 50-58.
97. Choi, H.S.; An, J.J.; Kim, S.Y.; Lee, S.H.; Kim, D.W.; Yoo, K.Y.; Won, M.H.; Kang, T.C.; Kwon, H.J.; Kang, J.H.; Cho, S.W.; Kwon, O.S.; Park, J.; Eum, W.S.; Choi, S.Y. PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model. Free Radic. Biol. Med., 2006, 41(7), 1058-1068.
98. Chuang, C.K.; Su, Y.S.; Fan, C.T.; Lee, W.C.; Chen, M.Y. A dual-functional E. coli vector for expressing recombinant protein with high solubility and antigen presentation ability. Protein. Expr. Purif., 2009, 65(1), 51-56.
99. Lopes, L.B.; Furnish, E.; Komalavilas, P.; Seal, B.L.; Panitch, A.; Bentley, M.V.; Brophy, C.M. Enhanced skin penetration of P20 phosphopeptide using protein transduction domains. Eur. J. Pharm. Biopharm., 2008, 68(2), 441-445.
100. Oueslati, M.; Hermosilla, R.; Schonenberger, E.; Oorschot, V.; Beyermann, M.; Wiesner, B.; Schmidt, A.; Klumperman, J.; Rosenthal, W.; Schulein, R. Rescue of a nephrogenic diabetes insipiduscausing vasopressin V2 receptor mutant by cell-penetrating peptides. J. Biol. Chem., 2007, 282(28), 20676-20685.
101. Choi, S.H.; Kim, D.W.; Kim, S.Y.; An, J.J.; Lee, S.H.; Choi, H.S.; Sohn, E.J.; Hwang, S.I.; Won, M.H.; Kang, T.C.; Kwon, H.J.; Kang, J.H.; Cho, S.W.; Park, J.; Eum, W.S.; Choi, S.Y. Transduced human copper chaperone for Cu,Zn-SOD (PEP-1-CCS) protects against neuronal cell death. Mol. Cells, 2005, 20(3), 401-408.
102. Nagel, F.; Bähr, M.; Dietz, G.P.H. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins. Brain Res. Bull., 2009, 79(5), 303-309.
103. Hou, Y.; Zou, J. Delivery of HSF1(+) protein using HIV-1 TAT protein transduction domain. Mol. Biol. Rep., 2009, 36(8), 2271-2277.
104. Xu, H.; Shi, Y.; Wang, J.; Jones, D.; Weilrauch, D.; Ying, R.; Wakim, B.; Pritchard, K.A., Jr. A heat shock protein 90 binding domain in endothelial nitric-oxide synthase influences enzyme function. J. Biol. Chem., 2007, 282(52), 37567-37574.